Levi’s Shares Fall as Sales Weakness Sparks Downbeat Outlook
Levi Strauss & Co. reported quarterly revenue that missed expectations as performance at retailers including department stores dragged
2023-10-06 07:20
Bunge shareholders approve merger with Viterra, closing expected in mid-2024
By Karl Plume Shareholders of global grains merchant and oilseeds processor Bunge approved the company's acquisition of Glencore-backed
2023-10-06 06:55
MGM expects cybersecurity issue to negatively impact third-quarter earnings
MGM Resorts International said on Thursday operational disruptions due to a cybersecurity issue in September are expected to
2023-10-06 06:15
Marketmind: One more firework in fiery start to Q4
By Jamie McGeever A look at the day ahead in Asian markets from Jamie McGeever, financial markets columnist.
2023-10-06 05:50
Mexico Stocks Sink After Government Alters Airport Fees
Mexico President Andres Manuel Lopez Obrador renewed his broadside challenge to the country’s business interests with an unexpected
2023-10-06 05:27
Explainer-Why are Kaiser Permanente healthcare workers on strike?
By Leroy Leo and Bhanvi Satija About 75,000 medical workers from Kaiser Permanente facilities went on a planned
2023-10-06 05:21
Sam Bankman-Fried Told MIT Friend $8 Billion Hole Meant FTX Wasn’t ‘Bulletproof’
FTX co-founder Gary Wang took the stand at Sam Bankman-Fried’s trial and almost immediately said he and his
2023-10-06 04:55
Sam Bankman-Fried demanded special privileges for his fund, ex-colleague testifies
By Luc Cohen and Jody Godoy NEW YORK (Reuters) -Sam Bankman-Fried's college roommate and ex-colleague, Gary Wang, testified on Thursday
2023-10-06 04:55
US jobs report stands as next catalyst for Treasury market gyrations
By Davide Barbuscia NEW YORK A wild week in Treasury markets is set to culminate with the U.S.
2023-10-06 04:15
There are cowboy boot Crocs now
It appears that the trusty, "sorry-not-sorry that I'm ugly" Crocs foam clog has found a way to get even weirder,
2023-10-06 03:50
Sanofi to Explore Acquisition of Cancer Drugmaker Mirati
French pharmaceutical giant Sanofi is exploring a potential acquisition of cancer drugmaker Mirati Therapeutics Inc., according to people
2023-10-06 03:26
Political Dysfunction Undermines US Forces, Pentagon’s No. 2 Says
The Pentagon’s No. 2 official said that the threat of a government shutdown and other internal upheaval in
2023-10-06 03:22